r GBT Stock Quote - Global Blood Therapeutics Inc Stock Price Today
TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds

Global Blood Therapeutics Inc
(NASDAQ : GBT)

( )
GBT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-1.14%78.631.2%$618.81m
AMGNAmgen Inc.
0.16%178.241.2%$557.24m
GILDGilead Sciences, Inc.
-0.22%67.380.9%$542.96m
BIIBBiogen Inc.
0.63%286.211.2%$478.24m
REGNRegeneron Pharmaceuticals, Inc.
-0.30%293.742.6%$304.78m
VRTXVertex Pharmaceuticals Incorporated
0.34%157.501.9%$219.69m
ALXNAlexion Pharmaceuticals, Inc.
0.51%117.742.0%$210.05m
ILMNIllumina, Inc.
-1.70%266.223.5%$198.41m
AAgilent Technologies, Inc.
-1.50%63.161.5%$196.40m
NKTRNektar Therapeutics
-0.77%79.966.0%$184.19m
INCYIncyte Corporation
2.64%68.432.5%$149.75m
BMRNBioMarin Pharmaceutical Inc.
4.77%92.494.4%$135.47m
SRPTSarepta Therapeutics, Inc.
1.85%91.6516.6%$126.22m
BLUEBluebird Bio, Inc.
0.62%188.1515.7%$98.65m
EXASExact Sciences Corporation
-1.95%51.8225.5%$98.64m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.